Log in

ASX:BDABOD Australia Stock Price, Forecast & News

-0.01 (-3.08 %)
(As of 05/13/2020)
Today's Range
Now: A$0.32
50-Day Range
MA: A$0.29
52-Week Range
Now: A$0.32
Volume75,095 shs
Average VolumeN/A
Market Capitalization$28.78 million
P/E RatioN/A
Dividend YieldN/A
BOD Australia Limited operates as a developer, manufacturer, distributor, and marketer of plant-based medicinal cannabis, health and supplement products, and cosmetic solutions primarily in Australia. Its medicines portfolio includes Enterofytol for treating irritable bowel syndrome; and SediStress, which is used for the reduction of stress and anxiety. The company distributes its products through a channel network of approximately 900 pharmacies. It offers products under the SediStress, BIOEFFECT, PINPOINT, Flexofytol, Enterofytol, MamaCare, and Pommade Devine brands. Bod Australia Limited has a research collaboration agreement with Cannabis Access Clinics. The company is based in Double Bay, Australia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.46 out of 5 stars

Industry, Sector and Symbol

Industry Household & Personal Products
Phone61 2 9199 5018



Sales & Book Value

Annual Sales$2.27 million
Cash FlowA$0.09 per share
Book ValueA$0.09 per share



Market Cap$28.78 million
Next Earnings DateN/A
OptionableNot Optionable

Receive BDA News and Ratings via Email

Sign-up to receive the latest news and ratings for BDA and its competitors with MarketBeat's FREE daily newsletter.

BOD Australia (ASX:BDA) Frequently Asked Questions

How has BOD Australia's stock been impacted by COVID-19 (Coronavirus)?

BOD Australia's stock was trading at A$0.19 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, BDA shares have increased by 65.8% and is now trading at A$0.32. View which stocks have been most impacted by Coronavirus.

How were BOD Australia's earnings last quarter?

BOD Australia Ltd (ASX:BDA) announced its quarterly earnings results on Thursday, February, 28th. The company reported ($0.05) earnings per share for the quarter. View BOD Australia's earnings history.

Has BOD Australia been receiving favorable news coverage?

News coverage about BDA stock has been trending positive this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. BOD Australia earned a news sentiment score of 2.4 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news aboutBOD Australia.

Who are some of BOD Australia's key competitors?

What other stocks do shareholders of BOD Australia own?

Based on aggregate information from My MarketBeat watchlists, some companies that other BOD Australia investors own include Syrah Resources (SYR), MGC Pharmaceuticals (MXC), Medlab Clinical (MDC), Lynas (LYC), iSignthis (ISX), Eclipx Group (ECX), Botanix Pharmaceuticals (BOT) and Auscann Group (AC8).

Who are BOD Australia's key executives?

BOD Australia's management team includes the following people:
  • Ms. Joanne Patterson, CEO, Director & Member of Medical Advisory Board
  • Mr. Craig Weller, COO & Member of Medical Advisory Board
  • Mr. George Livery, Exec. Chairman (Age 52)
  • Dr. Adele Hosseini, Chief Scientific Officer & Member of Medical Advisory Board
  • Mr. Stephen Thompson, Exec. Director

What is BOD Australia's stock symbol?

BOD Australia trades on the ASX under the ticker symbol "BDA."

What is BOD Australia's stock price today?

One share of BDA stock can currently be purchased for approximately A$0.32.

How big of a company is BOD Australia?

BOD Australia has a market capitalization of $28.78 million and generates $2.27 million in revenue each year.

What is BOD Australia's official website?

The official website for BOD Australia is bodaustralia.com.

How can I contact BOD Australia?

The company can be reached via phone at 61 2 9199 5018.

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.